Telomerase activity in benign and malignant adrenal tumors

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 4, 1999, Pages 272-275

  Bamberger, Christoph M ^a,b   Else, T ^a   Bamberger, A M ^b   Frilling, A ^c   Beil, F U ^b   Allolio, B ^d   Schulte, H M ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Adrenal tumors; Telomerase

Indexed keywords

TELOMERASE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL TUMOR; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; CUSHING DISEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; PHEOCHROMOCYTOMA; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

EID: 0033061156     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212111     Document Type: Article

References (28)

1. Allsopp RC, Chang E, Kashefi Aazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB: Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220: 194-200, 1995
2. Autexier C, Greider CW: Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci 21: 387-391, 1996
3. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch Hancke C, Abdelhamid S, Chrousos GP, Allolio B: Clonal composition of human adrenocortical neoplasms. Cancer Res 54: 4927-4932, 1994
4. Blackburn EH: Telomeres. Trends Biochem Sci 16: 378-381, 1991
5. Blasco MA, Lee H-W, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider C: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34, 1997
6. Blasco MA, Rizen M, Greider CW, Hanahan D: Differential regulation of telomerase activity and telomerase RNA during multistage tumorigenesis. Nat Genet 12: 200-204, 1996
7. Bodnar AG, Kim NW, Effros RB, Chiu CP: Mechanism of telomerase induction during T cell activation. Exp Cell Res 228: 58-64, 1996
8. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. Embo J 14: 4240-4248, 1995
9. Gicquel C, Leblond Francillard M, Bertagna X, Louvel A, Chapuis Y, Luton JP, Girard F, Le Bouc Y: Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol Oxf 40: 465-477, 1994
10. Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV: Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Mod Pathol 6: 663-668, 1993
11. Greider CW: Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95: 90-92, 1998
12. Greider CW: Telomere length regulation. Annu Rev Biochem 65: 337-365, 1996
13. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282, 1991
14. Harley CB, Kim NW: Telomerase and cancer. Important Adv Oncol 57-67, 1996
15. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995
16. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL. Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer [see comments]. Science 266: 2011-2015, 1994
17. Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, Yamada H, Terachi T, Yoshida O: Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 89: 724-730, 1997
18. Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K: Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82: 176-179, 1998
19. Marx C, Wolkersdorfer GW, Brown JW, Scherbaum WA, Bornstein SR: MHC class II expression - a new tool to assess dignity in adrenocortical tumours. J Clin Endocrinol Metab 81: 4488-4491, 1996
20. Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K, Kinugasa N, Yoshida K, Uematsu S, Tsuji T: Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 78: 232-236, 1996
21. Rhyu MS: Telomeres, telomerase, and immortality. J Natl Cancer Inst 87: 884-894, 1995
22. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997
23. Shay JW, Wright WE: The reactivation of telomerase activity in cancer progression. Trends Genet 12: 129-131, 1996
24. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222, 1996
25. van Steensel B, de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743, 1997
26. Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, Wadsworth S, Mortensen NJ, Toge T, Tahara E, Tarin D: Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer 75: 548-553, 1997
27. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeuku J, Nargund V, Fellows G, Goodison S, Tahara E, Tarin D: Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 79: 362-369, 1997
28. Yu GL, Bradley JD, Attardi LD, Blackburn EH: In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126-132, 1990